ADT Side Effects in Prostate Cancer
Androgen deprivation therapy (ADT) lowers testosterone to control prostate cancer. Because testosterone acts throughout the body, side effects are not limited to sexual function. Hot flushes, reduced libido, erectile dysfunction, fatigue, loss of muscle, increased body fat, insulin resistance and bone thinning are common concerns. Some men also notice mood, sleep or concentration changes. The exact burden depends on age, duration of treatment, baseline health and which additional cancer medicines are used. Side-effect prevention should begin when ADT starts — especially exercise, cardiovascular-risk monitoring and bone-health assessment — rather than waiting until problems become severe.
Common side effects and what helps
| Side effect | Why it happens | What may help |
|---|---|---|
| Hot flushes | Loss of normal sex-hormone regulation | Layered clothing, trigger avoidance, cooling strategies and prescription treatment when severe. |
| Low libido / erectile dysfunction | Testosterone suppression and reduced sexual arousal | Open discussion, PDE5 inhibitors or other ED treatment when appropriate; couple counselling when useful. |
| Fatigue | Hormonal change, muscle loss, sleep disturbance, cancer itself | Regular exercise, sleep review, anaemia/thyroid/other-cause assessment when disproportionate. |
| Muscle loss / fat gain | Reduced anabolic signalling and metabolic change | Progressive resistance training, aerobic exercise and adequate protein. |
| Bone thinning | Testosterone and oestrogen decline accelerate bone resorption | DEXA when indicated, weight-bearing exercise, calcium/vitamin D adequacy and prescription therapy for high fracture risk. |
| Glucose/lipid changes | Increased insulin resistance and altered body composition | Weight control, BP/HbA1c/lipid monitoring and treatment of cardiovascular risk factors. |
| Mood / cognitive symptoms | Multifactorial; hormonal change, sleep and illness burden | Screen for depression/anxiety, optimize sleep and medications; seek help if function is affected. |
Bone health needs a plan
Long-term ADT increases fracture risk. Baseline fracture history, age, weight, smoking, alcohol, steroid use and other risk factors help decide whether a DEXA scan is needed. Bone-protective drugs are used when osteoporosis or significant fracture risk is present, not automatically for every patient.
Cardiovascular and metabolic health
ADT can worsen blood pressure, weight, glucose and lipid profile. Men with pre-existing heart disease need particularly careful risk-factor management. This does not mean ADT should be avoided when it is important for cancer control; it means cancer treatment and cardiovascular prevention should proceed together.
Exercise is part of treatment
Combined resistance and aerobic exercise can help preserve muscle, strength, physical function and cardiometabolic health. The programme should match baseline fitness, bone metastases and fall/fracture risk. A patient with unstable bone lesions needs a modified plan rather than unsupervised heavy lifting.
Sexual and relationship effects
Loss of libido can be more disruptive than erection quality alone. Partners may misinterpret reduced sexual interest as emotional withdrawal. Explaining the hormonal mechanism and discussing non-penetrative intimacy, erectile treatments and counselling can reduce avoidable distress.
When symptoms need medical review
- New chest pain, breathlessness or neurological symptoms.
- Rapid functional decline or repeated falls.
- New focal bone pain or suspected fracture.
- Severe depression, hopelessness or thoughts of self-harm.
- Marked swelling, uncontrolled blood pressure or other symptoms related to additional systemic medicines.
Do side effects reverse after ADT stops?
Some do, especially hot flushes, libido and energy, but recovery depends on age, ADT duration and whether testosterone returns. After prolonged treatment, testosterone can take many months to recover and may remain low in some older men. Bone and metabolic effects may persist, so health monitoring should continue.
A baseline health check makes ADT safer
| Before or early in long-term ADT | Why it matters |
|---|---|
| Weight, waist, blood pressure | Tracks metabolic and cardiovascular change. |
| Glucose/HbA1c and lipid profile | ADT can worsen diabetes risk and dyslipidaemia. |
| Bone history and bone-mineral density when indicated | Identifies men who need fracture-prevention treatment. |
| Exercise and falls assessment | Protects muscle, balance and independence. |
| Sexual, mood and cognitive symptoms | Creates a baseline so new problems are recognized rather than dismissed. |
ADT side-effect care is part of cancer treatment, not a separate lifestyle add-on. The longer treatment is expected to continue, the more important structured monitoring becomes.
Bone protection is more than calcium tablets
Fracture prevention starts with estimating baseline risk, not automatically prescribing supplements. Weight-bearing and resistance exercise, adequate dietary calcium, vitamin D when deficient, smoking cessation, alcohol moderation and fall prevention all matter. DEXA scanning and FRAX-based assessment help identify men who need pharmacological bone protection.
Men with bone metastases need a separate discussion because bone-targeted agents can be used for different reasons in metastatic disease. Dental assessment is important before some antiresorptive treatments because medication-related osteonecrosis of the jaw, although uncommon, is a recognised complication.
Cardiovascular symptoms should not be normalised as “just ADT”
Fatigue and reduced exercise capacity are common, but new chest pain, marked breathlessness, syncope, new leg swelling or a major decline in exercise tolerance deserves medical evaluation. Cancer control and cardiovascular risk reduction should proceed together, particularly in men with established heart disease or multiple metabolic risk factors.
When to seek urgent medical care
Chest pain, severe breathlessness, fainting, new one-sided weakness, sudden severe headache, or a painful swollen leg need urgent assessment and should not be assumed to be “just an ADT side effect.” New severe back pain with leg weakness, numbness or loss of bladder/bowel control also needs emergency evaluation because prostate cancer can affect the spine.
Consultation checklist
- ADT drug name and injection/tablet schedule.
- Other prostate-cancer medicines.
- Blood pressure, weight and waist trend.
- HbA1c/fasting glucose and lipid profile.
- DEXA scan or fracture history.
- Cardiovascular history and medicines.
- Exercise level, falls and new bone pain.
- Symptoms you want addressed: hot flushes, libido, erections, fatigue, sleep or mood.
FAQs
Does everyone on ADT gain weight?
No, but body composition commonly shifts toward less muscle and more fat. Early exercise and nutrition support can reduce this.
Can I build muscle while on ADT?
Yes, although gains may be slower. Progressive resistance training remains beneficial and is strongly encouraged when safe.
Should every patient take calcium tablets?
Not automatically. Dietary intake, vitamin D status, kidney-stone history and fracture risk should be considered before supplementation.
Will erectile-dysfunction tablets work during ADT?
They can help some men, but very low libido from testosterone suppression may limit benefit. Vacuum devices, injections or other options can be discussed.
Can ADT affect memory?
Some men report cognitive changes, but causes are often multifactorial. Persistent or significant symptoms deserve assessment for sleep, mood, medication effects and other medical causes as well as ADT.
Related reading
- Hormone Therapy for Prostate Cancer
- Metastatic Prostate Cancer Explained
- Erectile Dysfunction After Prostate Cancer Treatment
- PSA After Prostate Cancer Treatment
- Urologist in Latur
References
- European Association of Urology (EAU). EAU Guidelines on Prostate Cancer. 2026 edition https://uroweb.org/guidelines/prostate-cancer
- National Cancer Institute. Prostate Cancer Treatment (PDQ®)–Patient Version https://www.cancer.gov/types/prostate/patient/prostate-treatment-pdq
- American Urological Association/SUO. Advanced Prostate Cancer Guideline (2020; amended 2026) https://www.auanet.org/guidelines-and-quality/guidelines/advanced-prostate-cancer